Unlisted
| Company Name | 주식회사 샤페론 |
| English Name | Shaperon Inc. |
| Business Reg. No. | 1018642705 |
| CEO | 성승용 |
| Address | 서울특별시 강남구 자곡로 174-10 강남에이스타워 606호(자곡동) |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 211 |
| Established | 20081001 |
| Phone | 02-6083-8315 |
| Website | shaperon.com |
| Regular Employees | 53persons |
| Corp. Reg. No. | 1101113977050 |
Venture Certified
| 기술평가보증기업(기금) | 2010-05-11 ~ 2012-05-10 | 20100103779 | 2010-04-16 |
| 기술평가보증기업(기금) | 2012-06-25 ~ 2014-06-24 | 20120105906 | 2010-04-16 |
| 기술평가보증기업(기금) | 2014-06-25 ~ 2016-06-24 | 20140107934 | 2010-04-16 |
| 벤처투자유형 | 2016-06-25 ~ 2018-06-24 | 20160300278 | 2010-04-16 |
| 벤처투자유형 | 2018-06-25 ~ 2020-06-24 | 20180300384 | 2010-04-16 |
| 벤처투자유형 | 2020-06-25 ~ 2022-06-24 | 20200300577 | 2010-04-16 |
| 벤처투자유형 | 2022-06-25 ~ 2025-06-24 | 20220615010008 | 2010-04-16 |
| 벤처투자유형 | 2025-06-25 ~ 2028-06-24 | 20250527010011 | 2010-04-16 |
Revenue CAGR -90.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.2B | 2.2B | 20B |
| Operating Profit | -151B | -132B | -110B |
| Net Profit | -149B | -124B | -107B |
| Total Assets | 193B | 250B | 352B |
| Total Liabilities | 33B | 60B | 59B |
| Total Equity | 160B | 190B | 293B |
Operating Loss: Op. profit -151B
Revenue down 92% YoY
3 Consecutive Years of Net Loss
▼ 98.4%
▼ 24.8%
▼ 2454.1%
▼ 20.6%
▼ 83.1%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 성승용 | 사내이사 | 대표이사 | - |
| 한상흥 | 사외이사 | 이사회 | - |
| 서충열 | 사외이사 | 이사회 | - |
| 김한수 | 감사 | 감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 50persons |
| CEO | 성승용 |
| Est. Avg. Annual Salary | 5,57910K (46510K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -6persons |
| Net Change (12 mo) | -6persons |
| NPS Join Date | 2012-02-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 강남구",
"ceo_name": "성승용",
"certificate": [
{
"cert_number": "20100103779",
"changes": "",
"disclosure_date": "2010-04-16",
"first_cert_date": "2010-04-16",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2010-05-11 ~ 2012-05-10"
},
{
"cert_number": "20120105906",
"changes": "",
"disclosure_date": "2012-06-25",
"first_cert_date": "2010-04-16",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-06-25 ~ 2014-06-24"
},
{
"cert_number": "20140107934",
"changes": "",
"disclosure_date": "2014-07-02",
"first_cert_date": "2010-04-16",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-06-25 ~ 2016-06-24"
},
{
"cert_number": "20160300278",
"changes": "",
"disclosure_date": "2016-06-09",
"first_cert_date": "2010-04-16",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2016-06-25 ~ 2018-06-24"
},
{
"cert_number": "20180300384",
"changes": "",
"disclosure_date": "2018-05-24",
"first_cert_date": "2010-04-16",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2018-06-25 ~ 2020-06-24"
},
{
"cert_number": "20200300577",
"changes": "",
"disclosure_date": "2020-05-21",
"first_cert_date": "2010-04-16",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2020-06-25 ~ 2022-06-24"
},
{
"cert_number": "20220615010008",
"changes": "",
"disclosure_date": "2022-06-15",
"first_cert_date": "2010-04-16",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2022-06-25 ~ 2025-06-24"
},
{
"cert_number": "20250527010011",
"changes": "",
"disclosure_date": "2025-05-27",
"first_cert_date": "2010-04-16",
"no": "8",
"type": "벤처투자유형",
"valid_period": "2025-06-25 ~ 2028-06-24"
}
],
"company_name": "(주)샤페론",
"financials": {
"2022": {
"capital_stock": 11238391000,
"cost_of_sales": 0,
"current_assets": 33732077000,
"current_liabilities": 3876376000,
"gross_profit": 2000000000,
"net_income": -10682790000,
"net_income_bs": -10672727000,
"non_current_assets": 1419183000,
"non_current_liabilities": 1995109000,
"non_operating_expenses": 69542000,
"non_operating_income": 416722000,
"operating_profit": -11029970000,
"revenue": 2000000000,
"sga_expenses": 13029970000,
"total_assets": 35151260000,
"total_equity": 29279775000,
"total_liabilities": 5871485000
},
"2023": {
"capital_stock": 11535516000,
"cost_of_sales": 0,
"current_assets": 20865180000,
"current_liabilities": 3203121000,
"gross_profit": 215251000,
"net_income": -11821216000,
"net_income_bs": -11837088000,
"non_current_assets": 4626844000,
"non_current_liabilities": 2751044000,
"non_operating_expenses": 150573000,
"non_operating_income": 991317000,
"operating_profit": -12661960000,
"revenue": 215251000,
"sga_expenses": 12877211000,
"total_assets": 25492024000,
"total_equity": 19537859000,
"total_liabilities": 5954165000
},
"2024": {
"capital_stock": 15071515000,
"cost_of_sales": 0,
"current_assets": 14753474000,
"current_liabilities": 2070326000,
"gross_profit": 17704000,
"net_income": -15341319000,
"net_income_bs": -15341319000,
"non_current_assets": 4490381000,
"non_current_liabilities": 1173351000,
"non_operating_expenses": 1774487000,
"non_operating_income": 482992000,
"operating_profit": -14049824000,
"revenue": 17704000,
"sga_expenses": 14067528000,
"total_assets": 19243855000,
"total_equity": 16000178000,
"total_liabilities": 3243677000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2020-10-16"
},
{
"amount": "1,679,956,667",
"changes": "1,679,956,667",
"date": "2020-09-28"
},
{
"amount": "2,240,032,667",
"changes": "2,240,032,667",
"date": "2020-09-28"
},
{
"amount": "4,000,000,000",
"changes": "4,000,000,000",
"date": "2020-09-28"
},
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2020-09-28"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2020-09-21"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2020-09-11"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2020-09-11"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2018-06-15"
},
{
"amount": "4,000,000,000",
"changes": "4,000,000,000",
"date": "2018-06-15"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2018-06-15"
},
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2018-06-15"
},
{
"amount": "3,999,970,000",
"changes": "3,999,970,000",
"date": "2018-06-15"
},
{
"amount": "2,239,978,000",
"changes": "2,239,978,000",
"date": "2018-06-15"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2016-02-05"
}
],
"phone": "02-6083-****",
"source": "pg_migration"
}{
"address": "서울특별시 강남구 자곡로",
"brno": "101864****",
"cappedWarning": false,
"companyName": "(주)샤페론(SHAPERON)",
"estimatedAvgAnnualSalary": 55791204,
"estimatedAvgMonthlySalary": 4649267,
"fetchedAt": "2026-03-05T11:27:20.482Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20120201",
"last12MonthsHired": 0,
"last12MonthsLeft": 6,
"last12MonthsNetChange": -6,
"leaveDate": null,
"monthlyPensionAmount": 22084020,
"monthlyTrend": [
{
"lostSubscribers": 6,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6725529",
"status": "1",
"styleCode": "1",
"subscriberCount": 50,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-28 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |